Third degree AV block screening: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Third degree AV block}} | {{Third degree AV block}} | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} {{ADG}} | ||
==Overview== | ==Overview== | ||
Revision as of 02:08, 11 April 2020
Third degree AV block Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Third degree AV block screening On the Web | |
American Roentgen Ray Society Images of Third degree AV block screening | |
Risk calculators and risk factors for Third degree AV block screening | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Aditya Ganti M.B.B.S. [3]
Overview
There is insufficient evidence to recommend routine screening for third degree AV block. However, screening for congenital AV block is recommended.
Screening
- There is insufficient evidence to recommend routine screening for third degree AV block. However, screening for congenital AV block is recommended.
- Recommendations include echocardiogram for newborns of pregnant women with SSA autoantiboides.
- Timing for screening:[1]
- Women with history of neonatal lupus, fetal echos are recommended weekly then repeating the echos every 3 or 4 weeks.
- Women with prior infant with lupus, echos are performed at the 16 weeks of gestation or 18 weeks.
- Fetal echos can be stopped by the 23 weeks of gestation.
References
- ↑ Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). "The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices". Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.